These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 19797220)

  • 21. Nucleolar size in choroidal and ciliary body melanomas and corresponding hepatic metastases.
    Al-Jamal RT; Toivonen P; Kivelä T
    Acta Ophthalmol; 2010 Jun; 88(4):458-62. PubMed ID: 19549104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
    Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4372-5. PubMed ID: 16303922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and cytogenetic analyses in uveal melanoma.
    Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
    Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.
    Shields CL; Kaliki S; Livesey M; Walker B; Garoon R; Bucci M; Feinstein E; Pesch A; Gonzalez C; Lally SE; Mashayekhi A; Shields JA
    JAMA Ophthalmol; 2013 Aug; 131(8):993-1003. PubMed ID: 23681424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Presence of a fluid-conducting meshwork in xenografted cutaneous and primary human uveal melanoma.
    Clarijs R; Otte-Höller I; Ruiter DJ; de Waal RM
    Invest Ophthalmol Vis Sci; 2002 Apr; 43(4):912-8. PubMed ID: 11923228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
    Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptors for the liver synthesized growth factors IGF-1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications.
    Economou MA; All-Ericsson C; Bykov V; Girnita L; Bartolazzi A; Larsson O; Seregard S
    Acta Ophthalmol; 2008 Nov; 86 Thesis 4():20-5. PubMed ID: 19032678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Prognostic study of malignant melanoma of the uvea treated by enucleation].
    Bacin F; Kantelip B; Albuisson E; Bonhomme R
    J Fr Ophtalmol; 1988; 11(10):639-49. PubMed ID: 3072363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ruthenium-106 plaque brachytherapy for thick posterior uveal melanomas.
    Kaiserman N; Kaiserman I; Hendler K; Frenkel S; Pe'er J
    Br J Ophthalmol; 2009 Sep; 93(9):1167-71. PubMed ID: 19570767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Survival, anatomic, and functional long-term results in choroidal and ciliary body melanoma after ruthenium brachytherapy (15 years' experience with beta-rays).
    Rouberol F; Roy P; Kodjikian L; Gérard JP; Jean-Louis B; Grange JD
    Am J Ophthalmol; 2004 May; 137(5):893-900. PubMed ID: 15126155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
    Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
    J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pigmented episcleral deposits after brachytherapy of uveal melanoma.
    Toivonen P; Kivelä T
    Ophthalmology; 2006 May; 113(5):865-73. PubMed ID: 16530837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The hierarchization of the prognostic factors in uveal malignant melanoma].
    Călugăru M; Mera M; Călugăru D
    Oftalmologia; 2000; 50(1):30-4. PubMed ID: 11021104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update on the management of posterior uveal melanoma.
    Zhao DY; Shields CL; Shields JA; Gunduz K
    J Ophthalmic Nurs Technol; 1998; 17(2):66-71. PubMed ID: 9677975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between microarray gene expression signature and extravascular matrix patterns in primary uveal melanomas.
    Onken MD; Lin AY; Worley LA; Folberg R; Harbour JW
    Am J Ophthalmol; 2005 Oct; 140(4):748-9. PubMed ID: 16226537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metastatic melanoma in the eye and orbit.
    Zografos L; Ducrey N; Beati D; Schalenbourg A; Spahn B; Balmer A; Othenin-Girard CB; Chamot L; Egger E
    Ophthalmology; 2003 Nov; 110(11):2245-56. PubMed ID: 14597536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Iris and anterior chamber angle neovascularization after iodine 125 brachytherapy for uveal melanoma.
    Detorakis ET; Engstrom RE; Wallace R; Straatsma BR
    Ophthalmology; 2005 Mar; 112(3):505-10. PubMed ID: 15745782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exudative retinal detachment from malignant uveal melanoma: predictors and prognostic significance.
    Kivelä T; Eskelin S; Mäkitie T; Summanen P
    Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2085-93. PubMed ID: 11481276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of circulating malignant cells and its correlation with prognostic factors and treatment in uveal melanoma. A prospective longitudinal study.
    Callejo SA; Antecka E; Blanco PL; Edelstein C; Burnier MN
    Eye (Lond); 2007 Jun; 21(6):752-9. PubMed ID: 16575415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.